Gary Goldenberg
Chief Medical Officer at Verrica Pharmaceuticals Inc. (VRCA)
Gary Goldenberg has filed 9 insider reports with the SEC since March 2021, as chief Medical Officer at Verrica Pharmaceuticals Inc. (VRCA). Gary Goldenberg made no open-market purchases or sales in the last 12 months. The latest filing, on February 6, 2025, reports grant or award at Verrica Pharmaceuticals Inc. (VRCA).
- Filings
- 9
- Companies
- 1
- Bought on market
- $50K
- Sold on market
- $330K
Companies where Gary Goldenberg is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | 120,110 | $50K | $330K | $2.10 | $2.74+30% | Feb 6, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Aug 24, 2023VRCAAmendment: Chief Medical Officer Goldenberg Gary was granted 50,000 shares, increasing direct ownership by 71% to 120,110 unitsForm 4Grant or award
- Aug 27, 2024-$35.2KVRCAChief Medical Officer Goldenberg Gary sold $35,161 worth of shares (13,489 units at $2.61), decreasing direct ownership by 13% to 94,261 unitsForm 4Open-market sale
- Jul 23, 2024-$131KVRCAChief Medical Officer Goldenberg Gary sold $130,653 worth of shares (18,507 units at $7.06), decreasing direct ownership by 15% to 107,750 unitsForm 4Open-market sale
- Mar 15, 2024VRCAGoldenberg Gary was granted 40,000 shares, increasing direct ownership by 46% to 126,257 unitsForm 4Grant or award
- Nov 15, 2023-$26.1KVRCAGoldenberg Gary sold $26,061 worth of shares (8,853 units at $2.94), decreasing direct ownership by 9% to 86,257 unitsForm 4Open-market sale
- Aug 24, 2023VRCASEC Form 4: Goldenberg Gary was granted 25,000 shares, increasing direct ownership by 36% to 95,110 unitsForm 4Grant or award
- Jul 24, 2023-$139KVRCASEC Form 4 filed by Goldenberg GaryForm 4Grant or awardOpen-market sale
- Jul 5, 2022+$50KVRCASEC Form 4: Goldenberg Gary bought $49,999 worth of shares (23,809 units at $2.10)Form 4Open-market purchase
Compare Gary Goldenberg with
- Gary Goldenberg vs John J. Kirby1 shared
- Gary Goldenberg vs Noah L. Rosenberg1 shared
- Gary Goldenberg vs David Zawitz1 shared
- Gary Goldenberg vs Jayson Rieger1 shared
- Gary Goldenberg vs Diem Nguyen1 shared
- Gary Goldenberg vs Mark A Prygocki Sr1 shared
Other insiders at the same companies
- John J. KirbyVRCA
- Jayson RiegerVRCA
- Noah L. RosenbergVRCA
- David ZawitzVRCA
- Diem NguyenVRCA
- Lawrence EichenfieldVRCA
- Mark A Prygocki SrVRCA
- Gavin CorcoranVRCA
- BKB Growth Investments, LLCVRCA
- Caligan Partners LPVRCA
- Charles FrantzrebVRCA
- Paul B ManningVRCA
- Christopher G. HayesVRCA
- Terry KohlerVRCA
- Ted WhiteVRCA
- Joe BonaccorsoVRCA
Questions about Gary Goldenberg
- What is Gary Goldenberg's role at Verrica Pharmaceuticals Inc.?
- Gary Goldenberg reports to the SEC as chief Medical Officer at Verrica Pharmaceuticals Inc. (VRCA), according to the latest filing on February 6, 2025.
- How many shares does Gary Goldenberg own?
- After the latest filing that states it, Gary Goldenberg directly owned 120,110 shares of Verrica Pharmaceuticals Inc. (VRCA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Gary Goldenberg bought or sold stock recently?
- The most recent open-market purchase was on July 5, 2022: bought 23,809 shares of Verrica Pharmaceuticals Inc. (VRCA) for $50K at an average of $2.10. The most recent open-market sale was on August 27, 2024: sold 13,489 shares of Verrica Pharmaceuticals Inc. (VRCA) for $35.2K at an average of $2.61.
- How do I get alerts when Gary Goldenberg files?
- Follow Gary Goldenberg on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Gary Goldenberg (SEC CIK 0001741938). Totals count each trade once, skipping amendments whose original is on file, from Mar 3, 2021 on. View on SEC EDGAR · Get this as JSON